Contact your GP urgently if you experience severe pain, signs of infection (increasing redness, warmth, discharge), or any concerning symptoms following injection
Data from a cross-sectional study found significantly higher mean levels of alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, bilirubin and superoxide dismutase in patients with cholecystitis versus a control group without cholecystitis
The prevalence appears to be higher among patients who experience significant gastrointestinal symptoms or those achieving rapid weight loss
pharmacies, we are able to offer you treatments at a fraction of the cost compared to other weight loss options
Safety Profile in Research Contexts Gastrointestinal events (nausea, vomiting, diarrhea, constipation) remain the most common adverse effects, typically mild to moderate, dose-dependent, and often mitigated by gradual dose escalation starting at lower levels (e.g., 2 mg)